Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes

Int J Environ Res Public Health. 2014 Feb 21;11(2):2328-45. doi: 10.3390/ijerph110202328.

Abstract

Bitter Melon (Momordica charantia) is a widely used traditional remedy for hyperglycemia. While the medicinal properties of this plant have been studied extensively using in vitro and animal models, the clinical efficacy and safety in humans is largely unknown. This review discusses the benefits and limitations of bitter melon supplementation in the context of epidemic levels of insulin resistance and pre-diabetes throughout the world.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Blood Glucose / drug effects
  • Humans
  • Insulin Resistance*
  • Momordica charantia*
  • Phytotherapy*
  • Plant Preparations / pharmacology
  • Plant Preparations / therapeutic use*
  • Prediabetic State / drug therapy*
  • Randomized Controlled Trials as Topic

Substances

  • Blood Glucose
  • Plant Preparations